You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

homologous recombination

Showing 1 - 25 of 390
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma, Homologous Recombination Deficiency Trial (Cisplatin)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Homologous Recombination Deficiency
  • (no location specified)
Oct 18, 2023

Homologous Recombination Repair Pathway Gene Mutation Spectrum

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    Jun 4, 2023

    Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

    Not yet recruiting
    • Ovarian Cancer
    • Olaparib tablet
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Nov 1, 2023

    Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer Trial in Shanghai (Fluzoparib, Irinotecan)

    Not yet recruiting
    • Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer
    • Shanghai, Shanghai, China
      Department of Colorectal Surgery Fudan University Shanghai Caner
    Feb 22, 2023

    Homologous Recombination Inquiry Through Ovarian Malignancy

    Completed
    • Ovarian Cancer
    • +2 more
      • Niigata city, Niigata Prefecture, Japan
        Niigata University Graduate School of Medical and Dental Science
      Jan 19, 2023

      HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer

      Completed
      • Epithelial Ovarian Cancer
      • +6 more
      • Evaluation of homologous recombination deficiency score
      • Beijing, Beijing, China
        Lei Li
      Mar 26, 2022

      Homologous Recombination Deficiency, Triple Negative Breast Cancer Trial (Niraparib)

      Not yet recruiting
      • Homologous Recombination Deficiency
      • Triple Negative Breast Cancer
      • (no location specified)
      Jul 15, 2022

      Solid Tumor, Adult Trial in Miami (Pembrolizumab 200 mg Q3W)

      Active, not recruiting
      • Solid Tumor, Adult
      • Pembrolizumab 200 mg Q3W
      • Miami, Florida
        Miami Cancer Institute at Baptist Health, Inc.
      Nov 18, 2022

      High-Grade Ovarian Cancer Terms of Homologous Recombination

      Not yet recruiting
      • Ovarian Cancer
      • +2 more
      • Standard of care
      • (no location specified)
      Oct 7, 2022

      Testing Circulating Tumour DNA for Homologous Recombination Gene

      Recruiting
      • Circulating Tumor DNA
      • Metastatic Prostate Cancer
      • Blood sample
      • Urine sample
      • Tours, France
        University hospital
      Sep 6, 2022

      HRD and Resistance to PAPPi in EOC Patients

      Recruiting
      • Epithelial Ovarian Cancer
      • +6 more
      • Testing of homologous recombination deficiency
      • Beijing, Beijing, China
        Lei Li
      Mar 26, 2022

      Melanoma Trial (Fluzoparib Camrelizumab Temozolomide)

      Not yet recruiting
      • Melanoma
      • Fluzoparib Camrelizumab Temozolomide
      • (no location specified)
      Aug 9, 2023

      HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

      Recruiting
      • HRD Cancer
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      Breast Cancer Trial in Amsterdam (carboplatin, thiotepa, and cyclophosphamide, chemo (docetaxel, doxorubicin, cyclofosfamide,

      Recruiting
      • Breast Cancer
      • carboplatin, thiotepa, and cyclophosphamide
      • chemotherapy (docetaxel, doxorubicin, cyclofosfamide, carboplatin, paclitaxel, gemcitabine)
      • Amsterdam, Netherlands
        NKI-AVL
      Mar 21, 2022

      Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

      Recruiting
      • Lung Cancer
        • Shanghai, China
          Shanghai Chest Hospital
        Jul 20, 2023

        Cancer Trial in Melbourne (Pamiparib, Tislelizumab)

        Recruiting
        • Cancer
        • Melbourne, Victoria, Australia
          Peter MacCallum Cancer Centre
        Mar 3, 2022

        Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer

        Not yet recruiting
        • Ovarian Cancer
        • HIPEC
        • (no location specified)
        Mar 2, 2022

        Homologous Recombination-related Genesmutationsand HRD in Breast

        Not yet recruiting
        • Breast Cancer
        • HER2-low Breast Cancer
        • Standard Management
        • Guangzhou, Guangdong, China
          Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
        Jul 18, 2022

        Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

        Active, not recruiting
        • Advanced Breast Cancer
        • +2 more
        • Talazoparib Tosylate
        • Stanford, California
          Stanford University Hospitals and Clinics
        Nov 16, 2022

        mCRPC Trial in Australia, China, United States (Placebo, Senaparib)

        Not yet recruiting
        • mCRPC
        • Binghamton, New York
        • +5 more
        Dec 14, 2021

        Metastatic Melanoma Trial in San Francisco (Niraparib)

        Recruiting
        • Metastatic Melanoma
        • San Francisco, California
          California Pacific Medical Center Research Institute
        Oct 15, 2021

        Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML

        Recruiting
        • Castration-resistant Prostate Cancer
        • Homologous Recombination Deficiency
        • Testosterone Enanthate 100 MG/ML Injectable Solution
        • Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
        • Sydney, New South Wales, Australia
          Kinghorn Cancer Centre, St. Vincent's Hospital
        Dec 16, 2022

        Breast Cancer Trial in Spain (Olaparib)

        Terminated
        • Breast Cancer
        • Barcelona, Spain
        • +7 more
        Jan 18, 2023

        Solid Tumor, Adult, Homologous Recombination Deficiency Trial in Washington, Hackensack, Charlotte (Niraparib, Carboplatin)

        Recruiting
        • Solid Tumor, Adult
        • Homologous Recombination Deficiency
        • Washington, District of Columbia
        • +2 more
        Aug 31, 2021

        Homologous Recombination Deficiency in Chinese Ovarian Cancer

        Not yet recruiting
        • Ovarian Cancer
        • +2 more
        • PARP inhibitor
        • Nanjing, Jiangsu, China
          Xiaoxiang Chen, MD,PhD
        Sep 4, 2021